Skip to content

Clinical trials

Completed Phase 2 Hyperinsulinism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Phase: Phase 2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20042
20051
20082
20091
20101
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital of Philadelphia3
Rijnstate Hospital2
Jack Yanovski, M.D.1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
New York Medical College1
Rezolute1
Takeda1
University Hospital, Basel, Switzerland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism11
Obesity5
Congenital Hyperinsulinism3
Diabetes Mellitus3
Diabetes Mellitus, Type 22
Insulin Resistance2
Digestive System Diseases1
Dyslipidemias1
Endocrine System Diseases1
Glucose Metabolism Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.